1 - 8 of 8 articles
The American Society of Addiction Medicine (ASAM) has taken the lead, under the mantle of the Coalition to Stop Opioid Overdose, in requesting that the Drug Enforcement Administration (DEA) retain telehealth flexibility for buprenorphine initiation. Starting patients on buprenorphine without...
Responding to an increasingly punitive approach nationally toward pregnant and postpartum women who use substances, the American Society of Addiction Medicine (ASAM) this month released a public policy statement calling for a reversal in the direction of comprehensive and evidence‐based care....
Beginning with the statement that the most effective treatments for opioid use disorder (OUD) are medications — methadone, buprenorphine, and naltrexone — an “issue brief” (it's actually quite long) from The Pew Charitable Trusts (Pew) released last week recommended that states set “core metrics...
More than 1,200 leaders in opioid treatment plan to convene in Baltimore later this month for the first in‐person conference of the American Association for the Treatment of Opioid Dependence (AATOD) since October 2019. Speakers including Rahul Gupta, M.D., director of the White House Office of...
Last week, George F. Koob, Ph.D., director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), underscored some of the agency's recent research findings in a blog warning American seniors about how drinking affects their health.
Last week, we asked the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for more detailed information on alcohol limits for older adults. Here is the emailed response from NIAAA director George F. Koob, Ph.D., and Aaron White, Ph.D., leader of the biometric and epidemiology branch of...
The discussions about rescheduling marijuana, currently on Schedule I of the Controlled Substances Act, which is reserved for illegal drugs, have been enthusiastic and resulted in a public relations boost for President Biden, who proposed it. The commercial marijuana industry, economists,...
The 2022 American Association for the Treatment of Opioid Dependence (AATOD) conference will be held in Baltimore Oct. 30–Nov. 3. For more information, go to https://www.eventscribe.net/2022/AATOD/
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.